Oligodendrocyte Progenitor Cell Transplantation Reduces White Matter Injury in a Fetal Goat Model

Yan Yue1, Bixin Deng1, Yan Zeng1

  • 1Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu, China.

PubMed

Insights

Human oligodendrocyte progenitor cells (hOPCs) successfully differentiated into mature oligodendrocytes in a fetal goat model, significantly reducing preterm white matter injury (PWMI) and showing therapeutic potential.

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Developmental Biology

Background:

  • Preterm white matter injury (PWMI) is a leading cause of neurological disability in premature infants.
  • Oligodendrocyte progenitor cells (OPCs) are the primary cells affected in PWMI.
  • Current treatments for PWMI are limited, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To evaluate the differentiation potential of human OPCs (hOPCs) in a fetal goat model of PWMI.
  • To assess the therapeutic efficacy of hOPC transplantation in mitigating PWMI.
  • To investigate the impact of hOPCs on myelin repair and the inflammatory environment.

Main Methods:

  • A fetal goat model of PWMI was established using hypoxic-ischemia (HI) induced by intermittent umbilical cord occlusion.
  • Twenty million hOPCs were administered intranasally 12 hours post-HI insult.
  • Brain tissues were analyzed for oligodendrocyte differentiation (MBP, MAG, NG2, A2B5), myelination (myelinated nerve fiber percentage, g-ratio), inflammation, and neurotrophic factors (ELISA).

Main Results:

  • Transplanted hOPCs survived and differentiated into mature oligodendrocytes (expressing MBP and MAG) in the white matter of HI-insulted goats.
  • hOPC administration significantly increased myelin basic protein (MBP) and myelin-associated glycoprotein (MAG) levels, indicating enhanced myelination.
  • hOPC treatment reduced PWMI markers, did not exacerbate inflammation, and modulated inflammatory/neurotrophic factors (decreased TNF-α, increased GDNF and BDNF).

Conclusions:

  • Exogenous hOPCs can differentiate into functional oligodendrocytes in the developing brain of fetal goats.
  • hOPC transplantation effectively alleviates hypoxic-ischemic brain injury and promotes myelin repair in a preclinical model.
  • hOPC transplantation represents a promising cell-based therapeutic strategy for treating preterm white matter injury.
Abstract

Related Concept Videos